TELA

Tela Bio Inc

TELA.US telabio.com
0.91
-0.01 (-0.68%)
USD · NASDAQ
52-week range
0.50
1.70
Trading at 34% of the 52-week range
Market Cap
40.91M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
-0.35
Div. Yield
N/A
% Institutions
65.91%
% Insiders
9.10%

1 Year

-42.4%

3 Year

-89.9%

10 Year

-93.2%
Description

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Company Information

Company Name
Tela Bio Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US8723811084
CIK: 0001561921
CUSIP: 872381108
Currency: USD
Full Time Employees: 218
Phone: 484 320 2930
Website: telabio.com
Fiscal Year End: December
IPO Date: Nov 08, 2019
Description:

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Address:

1 Great Valley Parkway, Malvern, PA, United States, 19355

People

Directors & Officers

Name Title Year Born
Mr. Jeffrey Blizard President 1969
Mr. Roberto E. Cuca J.D. CFO, Corporate Secretary & COO 1968
Ms. Megan Smeykal VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer 1976
Mr. Paul Talmo Chief Technology Officer 1967
Mr. D. Taylor Ocasio General Counsel & Corporate Secretary NA
Mr. Jim Hagen Senior VP of Strategic Commercial Operations & Marketing NA
Ms. Jennifer Lou Armstrong Senior Vice President of Human Resources 1970
Mr. Gregory A. Firestone Chief Business Officer 1959
Mr. Michael Leonard Senior Vice President of Technical Operations NA
Dr. Howard N. Langstein Chief Medical Officer 1959

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Nov 17, 2025 Ew Healthcare Partners Fund 2, N/A Purchase 3.60M $1.11 $4.00M

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Essex Woodlands Health Ventures 7.71M Jun 30, 2026 17.18% $2.28 0.00%
Nantahala Capital Management, LLC 5.14M Mar 31, 2026 11.46% $0.12 0.64%
Stonepine Capital Management Llc 2.62M Mar 31, 2026 5.83% $0.65 11.28%
SILVERARC CAPITAL MANAGEMENT, LLC 2.26M Mar 31, 2026 5.03% $0.14 -14.66%
Vanguard Capital Management, LLC 1.54M Mar 31, 2026 3.43% $0.00 0.00%
Dafna Capital Management LLC 1.44M Mar 31, 2026 3.21% $0.20 0.00%
Perkins Capital Management Inc 1.42M Mar 31, 2026 3.16% $0.82 1.50%
UBS Group AG 1.06M Mar 31, 2026 2.36% $0.00 -29.39%
Citigroup Inc 750.00K Mar 31, 2026 1.67% $0.00 0.00%
Sio Capital Management, LLC 636.30K Jun 30, 2026 1.42% $0.08 0.00%
BlackRock Inc 465.81K Mar 31, 2026 1.04% $0.00 0.75%
WEALTHTRUST AXIOM LLC 457.73K Jun 30, 2026 1.02% $0.08 21.43%
Geode Capital Management, LLC 455.06K Mar 31, 2026 1.01% $0.00 25.88%
Vanguard Fiduciary Trust Co 211.66K Mar 31, 2026 0.47% $0.00 0.00%
Northern Trust Corp 174.40K Mar 31, 2026 0.39% $0.00 0.00%
UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC 99.89K Mar 31, 2026 0.22% $0.07 0.00%
State Street Corp 63.38K Mar 31, 2026 0.14% $0.00 0.00%
PNC Financial Services Group Inc 53.61K Mar 31, 2026 0.12% $0.00 0.00%
Renaissance Technologies Corp 52.60K Mar 31, 2026 0.12% $0.00 -59.13%
RWM Asset Management, LLC 52.50K Mar 31, 2026 0.12% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 1.15M 2.56% ▲ 0.00% Jul 31, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 389.47K 0.87% ▲ 0.00% Jul 31, 2026
3 Fidelity Extended Market Index 188.40K 0.42% ▼ 0.19% Jul 31, 2026
4 Jacob Small Cap Growth Investor 81.00K 0.18% ▼ 44.90% Jun 30, 2026
5 Jacob Discovery Fd Instl 79.78K 0.18% ▼ 33.40% Jun 30, 2026
6 Fidelity Total Market Index 66.81K 0.15% ▲ 0.00% Jul 31, 2026
7 Perkins Discovery 64.00K 0.14% ▲ 0.00% Mar 31, 2026
8 Fidelity Series Total Market Index 55.41K 0.12% ▲ 0.00% Jul 31, 2026
9 Extended Equity Market Fund E 40.52K 0.09% ▲ 0.00% Dec 31, 2025
10 Blackrock Extended Mkt Fund CF 40.52K 0.09% ▲ 0.00% May 31, 2026

Financial Highlights

Market Cap: $40.91M
EBITDA: $-33.01M
Book Value: $-0.35
Earnings/Share: $-0.85
Profit Margin: -51.53%
Operating Margin: -48.12%
ROA (TTM): -33.40%
ROE (TTM): -616.62%
Revenue (TTM): $79.91M
Revenue/Share (TTM): $1.51
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -4.50%

Valuation Metrics

Enterprise Value: $63.45M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 44.89M
Shares Float: 21.62M
% Insiders: 9.10%
% Institutions: 65.91%
Short % Float: 1.09%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$80.28M
Cost of Goods Sold
adjust
$-25.93M
Gross Profit
subtotal
$54.34M
SG&A
adjust
$-15.69M
R&D
adjust
$-9.22M
Other Operating Expense
adjust
$-63.18M
Operating Income
subtotal
$-33.76M
Other / Non-Operating Items
adjust
$-5.08M
Net Income
subtotal
$-38.83M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TELA.US!